Development of anti-GD2 Antibody-producing Mesenchymal Stem Cells as Cellular Immunotherapy.
Anticancer Res
; 43(6): 2417-2424, 2023 Jun.
Article
in En
| MEDLINE
| ID: mdl-37247922
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Mesenchymal Stem Cells
/
Antibodies, Monoclonal
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Anticancer Res
Year:
2023
Document type:
Article